MALT lymphoma · 7 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Amoxicillin, Clarithromycin, Omeprazole, Bismuth Variant #01 Partial | — | R 15 878 | 56d | — | — | ~2 | ~R 31 756 indirect | — |
Clarithromycin, Tetracycline, Omeprazole, Bismuth Variant #01 Partial | — | R 13 854 | 56d | — | — | ~2 | ~R 27 709 indirect | — |
Clarithromycin, Metronidzole, Omeprazole Variant #01 | — | R 5 125 | 10d | — | — | ~1 | ~R 5 125 indirect | — |
Amoxicillin and Omeprazole Variant #01 | — | R 3 597 | 14d | — | — | ~1 | ~R 3 597 indirect | — |
Metronidazole, Tetracycline, Omeprazole, Bismuth Variant #01 Partial | — | R 3 025 | 56d | — | — | ~2 | ~R 6 051 indirect | — |
Ampicillin, Metronidazole, Bismuth Variant #01 Partial | — | — | — | — | — | ~1 | — | — |
Ampicillin and Omeprazole Variant #01 Partial | — | — | — | — | — | ~1 | — | — |
7 of 7 regimens shown